[Alzheimer disease, memory and estrogen].
Epidemiological studies of Alzheimer disease have shown a higher prevalence of women. Some data argue for a link between Alzheimer disease and the decrease of estrogen in post-menopausal women. Animal studies have shown a beneficial effect of estrogen on memory with a decrease of amyloid deposition in models of AD, whereas estrogen has a positive effect on BDNF. Six studies have shown a positive effect of estrogen therapy on memory and studies on structural and functional imaging have shown a beneficial effect of estrogens but the largest study on prevention of dementia with estrogens (WHI) showed a deleterious effect. To better understand this paradoxical situation, we reviewed the literature on estrogens, memory and Alzheimer disease. We first discuss the promnesic effect of estrogen on mice and rats, second the neuroprotector effect of estrogen on animal models of Alzheimer disease, and third the available human studies. We hypothesize a link with the time of instauration of the estrogen treatment. Nevertheless this hypothesis remains to be demonstrated.
Blanc
F
F
Service de Neuropsychologie, Département de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Poisbeau
P
P
Sellal
F
F
Tranchant
C
C
de Seze
J
J
André
G
G
D000368:Aged; D000544:Alzheimer Disease / Q000453:epidemiology* / Q000517:prevention & control* / Q000523:psychology; D000818:Animals; D053327:Apolipoprotein E4 / Q000378:metabolism; D002986:Clinical Trials as Topic; D003071:Cognition / Q000502:physiology; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000502:physiology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008568:Memory / Q000502:physiology*; D051379:Mice; D008875:Middle Aged; D010275:Parasympathetic Nervous System / Q000503:physiopathology; D051381:Rats; D012737:Sex Factors
D053327:Apolipoprotein E4; D004967:Estrogens